Skip to main content
Year archive

Luye Pharma Group Limited — 2023 filings

All 95 regulatory filings released by Luye Pharma Group Limited (2186) in 2023, sourced directly from the official regulator.

95 Filings
2023 Period
2023 filings (95)
Filing Released Lang
Interim Report 2023
Regulatory Filings
2023-12-18 English
VOLUNTARY ANNOUNCEMENT - INNOVATIVE FORMULATIONS BAITUOWEI AND RYKINDO INCLUDED ON CHINA'S 2023 NATIONAL REIMBURSEMENT DRUG LIST
Regulatory Filings
2023-12-13 English
VOLUNTARY ANNOUNCEMENT - INNOVATIVE DRUG LURBINECTEDIN APPROVED FOR MARKETING IN HONG KONG
Regulatory Filings
2023-12-12 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2023-12-06 English
CHANGE OF NON-EXECUTIVE DIRECTOR
Regulatory Filings
2023-12-06 English
VOLUNTARY ANNOUNCEMENT - INNOVATIVE DRUG LURBINECTEDIN APPROVED FOR THE TREATMENT OF RELAPSED SMALL CELL LUNG CANCER IN MACAO, CHINA
Regulatory Filings
2023-12-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Regulatory Filings
2023-12-01 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023
Regulatory Filings
2023-11-27 English
NOTICE OF BOARD MEETING
Regulatory Filings
2023-11-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Regulatory Filings
2023-11-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-11-03 English
VOLUNTARY ANNOUNCEMENT - RIVASTIGMINE TWICE WEEKLY TRANSDERMAL PATCH APPROVED FOR MARKETING IN CHINA
Regulatory Filings
2023-10-31 English
ANNOUNCEMENT IN RELATION TO THE 2022 ANNUAL REPORT
Regulatory Filings
2023-10-13 English
VOLUNTARY ANNOUNCEMENT - THE COMPANY SUBMITTED NDA FOR PALIPERIDONE PALMITATE EXTENDED-RELEASE INJECTABLE SUSPENSION (LY03010) TO THE FDA
Regulatory Filings
2023-10-09 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-10-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Regulatory Filings
2023-10-06 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-10-05 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-10-03 English
Interim Report 2023
Regulatory Filings
2023-09-28 English
VOLUNTARY ANNOUNCEMENT - THE BREAST CANCER INDICATION OF BAITUOWEI (GOSERELIN MICROSPHERES FOR INJECTION) APPROVED IN CHINA
Regulatory Filings
2023-09-07 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-09-06 English
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Regulatory Filings
2023-09-04 English
Next Day Disclosure Return
Regulatory Filings
2023-09-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
Regulatory Filings
2023-09-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-09-04 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
Regulatory Filings
2023-08-29 English
MEMORANDUM OF ASSOCIATION AND BYE-LAWS
Regulatory Filings
2023-08-22 English
SUPPLEMENTAL ANNOUNCEMENT - POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 11 AUGUST 2023
Regulatory Filings
2023-08-22 English
List of Directors and their Roles and Functions
Regulatory Filings
2023-08-22 English
APPOINTMENT OF EXECUTIVE DIRECTORS AND CHIEF EXECUTIVE OFFICER
Regulatory Filings
2023-08-22 English
VOLUNTARY ANNOUNCEMENT - SUBMISSION OF NEW DRUG APPLICATION FOR LURBINECTEDIN BY THE GROUP IN MACAO, CHINA
Regulatory Filings
2023-08-21 English
VOLUNTARY ANNOUNCEMENT - RYKINDO ENTERED COMMERCIAL OPERATION IN THE UNITED STATE MARKET
Regulatory Filings
2023-08-17 English
NOTICE OF BOARD MEETING
Regulatory Filings
2023-08-16 English
SUPPLEMENTAL ANNOUNCEMENT - PLACING UNDER GENERAL MANDATE
Regulatory Filings
2023-08-15 English
PLACING OF NEW SHARES UNDER GENERAL MANDATE
Regulatory Filings
2023-08-14 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 11 AUGUST 2023
Regulatory Filings
2023-08-11 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-08-04 English
DISCLOSEABLE TRANSACTION COMPLETION OF THE ACQUISITION OF INTEREST IN THE BUSINESS OF UNMANNED AERIAL VEHICLES INVOLVING ISSUE OF CONSIDERATION SHARES UNDER GENERAL MANDATE
Regulatory Filings
2023-08-01 English
Next Day Disclosure Return
Regulatory Filings
2023-08-01 English
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF THE NDA AND PRIORITY REVIEW GRANTED FOR ROTIGOTINE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY03003) BY NMPA IN CHINA
Regulatory Filings
2023-08-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings
2023-08-01 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2022/23
Regulatory Filings
2023-07-19 English
Annual Report 2022/23
Regulatory Filings
2023-07-19 English
Form of proxy for use by shareholders at the Annual General Meeting to be convened on Friday, 11 August 2023 at 10:00 a.m.
Regulatory Filings
2023-07-19 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2023-07-19 English
GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; RE-ELECTION OF DIRECTORS&#x3b; RE-APPOINTMENT OF INDEPENDENT AUDITOR&#x3b; PROPOSED AMENDMENTS TO THE BYE-LAWS AND THE ADOPTION OF NEW BYE-
Regulatory Filings
2023-07-19 English
PROPOSED AMENDMENTS TO THE BYE-LAWS AND ADOPTION OF AMENDED AND RESTATED BYE-LAWS
Regulatory Filings
2023-07-19 English
Publication of the Offering Circular of U.S.$180,000,000 6.25 per cent. Convertible Bonds due 2028 issued by Luye Pharma Group Ltd.
Regulatory Filings
2023-07-07 English
VOLUNTARY ANNOUNCEMENT - PATIENT ENROLLMENT COMPLETED FOR THE PHASE 2 CLINICAL STUDY OF NEW CLASS 1 DRUG LY03014 IN CHINA
Regulatory Filings
2023-07-06 English
Completion of the Issue of U.S.$180,000,000 6.25 per cent. Convertible Bonds due 2028
Regulatory Filings
2023-07-06 English
Notice of Listing of U.S.$180,000,000 6.25 per cent. Convertible Bonds due 2028 issued by Luye Pharma Group Ltd.
Regulatory Filings
2023-07-06 English
VOLUNTARY ANNOUNCEMENT - MARKETING REGISTRATION OF GOSERELIN MICROSPHERES FOR INJECTION (BAITUOWEI) APPROVED BY NMPA
Regulatory Filings
2023-07-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings
2023-07-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-06-30 English
PROPOSED ISSUE OF US$180,000,000 6.25 PER CENT. CONVERTIBLE BONDS DUE 2028
Regulatory Filings
2023-06-28 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2023
Regulatory Filings
2023-06-26 English
VOLUNTARY ANNOUNCEMENT - MARKETING REGISTRATION OF XUEZHIKANG APPROVED IN UZBEKISTAN
Regulatory Filings
2023-06-08 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-06-07 English
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF THE NDA FOR LURBINECTEDIN BY NMPA IN CHINA
Regulatory Filings
2023-06-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Regulatory Filings
2023-06-01 English
DATE OF BOARD MEETING
Regulatory Filings
2023-05-30 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2023-05-25 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 25 MAY 2023 AND APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Regulatory Filings
2023-05-25 English
DISCLOSEABLE TRANSACTION DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL OF A WHOLLY-OWNED SUBSIDIARY
Regulatory Filings
2023-05-17 English
SUPPLEMENTAL ANNOUNCEMENT ON DISCLOSEABLE TRANSACTION IN RELATION TO THE PROPOSED ACQUISITION OF INTEREST IN THE BUSINESS OF UNMANNED AERIAL VEHICLES
Regulatory Filings
2023-05-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
Regulatory Filings
2023-05-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-05-02 English
VOLUNTARY ANNOUNCEMENT - LURBINECTEDIN RECOMMENDED FOR THE FIRST TIME BY THE 2023 CSCO GUIDELINES FOR SMALL CELL LUNG CANCER
Regulatory Filings
2023-04-27 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 25 MAY 2023
Regulatory Filings
2023-04-27 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2023-04-27 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS INCLUDING INDEPENDENT NON-EXECUTIVE DIRECTORS WHO HAVE SERVED MORE THAN NINE YEARS OF THE COM
Regulatory Filings
2023-04-27 English
Environmental, Social and Governance Report 2022
Regulatory Filings
2023-04-27 English
Annual Report 2022
Regulatory Filings
2023-04-27 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Regulatory Filings
2023-04-11 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-03-31 English
VOLUNTARY ANNOUNCEMENT - LURBINECTEDIN FOR INJECTION (LY01017) GRANTED PRIORITY REVIEW BY CHINA'S CDE FOR TREATING SMALL CELL LUNG CANCER
Regulatory Filings
2023-03-31 English
Terms of Reference for the Environmental, Social and Governance Committee of the board of directors of the Company
Regulatory Filings
2023-03-29 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2023-03-29 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022
Regulatory Filings
2023-03-29 English
DISCLOSEABLE TRANSACTION IN RELATION TO THE PROPOSED ACQUISITION OF INTEREST IN THE BUSINESS OF UNMANNED AERIAL VEHICLES INVOLVING ISSUE OF CONSIDERATION SHARES UNDER GENERAL MANDATE
Regulatory Filings
2023-03-29 English
NOTICE OF BOARD MEETING
Regulatory Filings
2023-03-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
Regulatory Filings
2023-03-01 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-03-01 English
VOLUNTARY ANNOUNCEMENT - APPROVAL OBTAINED FOR INITIATING CLINICAL TRIAL IN EUROPE FOR PALIPERIDONE PALMITATE PROLONGED RELEASE SUSPENSION FOR INJECTION (LY03010)
Regulatory Filings
2023-02-23 English
Next Day Disclosure Return
Regulatory Filings
2023-02-22 English
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Regulatory Filings
2023-02-22 English
PLACING OF NEW SHARES UNDER GENERAL MANDATE
Regulatory Filings
2023-02-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings
2023-02-01 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-02-01 English
VOLUNTARY ANNOUNCEMENT - APPROVAL OBTAINED FOR INITIATING CLINICAL TRIAL IN CHINA FOR THE 3-MONTH DOSING FORM OF GOSERELIN ACETATE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY01022)
Regulatory Filings
2023-01-30 English
VOLUNTARY ANNOUNCEMENT - LIPUSU HAS BEEN SUCCESSFULLY RENEWED ITS INCLUSION IN CHINA'S NATIONAL REIMBURSEMENT DRUG LIST (2022 VERSION)
Regulatory Filings
2023-01-19 English
VOLUNTARY ANNOUNCEMENT - RYKINDO APPROVED BY THE FDA FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR I DISORDER
Regulatory Filings
2023-01-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Regulatory Filings
2023-01-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-01-03 English